Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 12/20 | 0.57 |
| ▸ | CDK1 | P06493 | 1/20 | 0.50 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.48 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TNF | P01375 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 1/20 | 0.47 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29954779 | 1.00 | ERN1 (0.57) | ERN1CDK1TRIM24TRIM33KDM4E | |
| Hydrochloric Acid SCHEMBL31191963 | 0.98 | ERN1 (0.55) | ERN1CDK1TRIM24TRIM33KDM4E | |
| SCHEMBL29955412 | 0.84 | ERN1 (0.67) | ERN1 | |
| SCHEMBL2558331 | 0.84 | ERN1 (0.67) | ERN1 | |
| 5-Bromosalicylaldehyde SCHEMBL28103357 | 0.82 | ERN1 (0.81) | ERN1CDK1KDM4EALDH1A1ALOX15 | |
| SCHEMBL6029813 | 0.82 | TYR (0.52) | ERN1TRIM24TRIM33KDM4EMEN1 | |
| SCHEMBL2554069 | 0.79 | ERN1 (0.65) | ERN1 | |
| SCHEMBL11664879 | 0.78 | LMNA (0.46) | KDM4EMEN1ALDH1A1CYP3A4THRB | |
| SCHEMBL22630789 | 0.77 | CA1 (0.46) | KDM4EMEN1ALDH1A1TNFCYP3A4 | |
| SCHEMBL3679569 | 0.77 | CA1 (0.46) | KDM4EMEN1ALDH1A1TNFCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118652281-A | Salamo-containing tetravalent platinum complex and preparation method and application thereof | 巴音郭楞蒙古自治州人民医院 | 2024-09-17 | — | — | CN | claimed |
| US-9334176-B1 | Method for removing organic dye from wastewater | KING SAUD UNIVERSITY (SA) | 2016-05-10 | — | — | US | claimed |
| US-5199954-A | Comprising methylcellulose, sorbitol, inorganic metal salt, citric acid, panthenol and water; stability, discoloration inhibition | SHISEIDO CO., LTD. (JP) | 1993-04-06 | — | — | US | claimed |
| CN-122080106-A | Oleanolic acid acylhydrazone derivative and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-118652281-A | Salamo-containing tetravalent platinum complex and preparation method and application thereof | 巴音郭楞蒙古自治州人民医院 | 2024-09-17 | — | — | CN | disclosed |
| WO-2024178390-A1 | COVALENT MODIFIERS OF AKT1 AND USES THEREOF | TERREMOTO BIOSCIENCES, INC. (US) | 2024-08-29 | — | — | WO | disclosed |
| US-20230349933-A1 | METABOLIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE | INSTITUT DE CARDIOLOGIE DE MONTREAL (CA) | 2023-11-02 | — | — | US | disclosed |
| WO-2023094734-A1 | LIGANDS SPECIFICALLY TARGETING VESICULAR GLUTAMATE TRANSPORTERS FOR SUPER-RESOLUTION IMAGING | Sorbonne Université (FR) | 2023-06-01 | — | — | WO | disclosed |
| US-20230123911-A1 | MODULATION OF IMMUNE CELLS | OCTAGON THERAPEUTICS, INC. | 2023-04-20 | — | — | US | disclosed |
| CN-109152772-B | Oral pharmaceutical composition of nicotinamide | 康纳里斯研究院股份公司 | 2021-09-28 | — | — | CN | disclosed |
| US-9603940-B2 | Metal salen complex derivative and process for production thereof | IHI CORPORATION (JP) | 2017-03-28 | — | — | US | disclosed |
| US-20020049154-A1 | Bioconjugates and delivery of bioactive agents | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2002-04-25 | — | — | US | disclosed |
| EP-1172106-A2 | Use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles as substance P receptor antagonists | Pfizer Products Inc. (US) | 2002-01-16 | — | — | EP | disclosed |
| US-6315978-B1 | FOR SITE SPECIFIC RELEASE IN CELLS, TISSUES OR ORGANS | UNIVERSITY OF UTAH, RESEARCH FOUNDATION | 2001-11-13 | — | — | US | disclosed |
| CN-1056373-C | Process for preparing fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles | PFIZER (US) | 2000-09-13 | — | — | CN | disclosed |
| EP-1007533-A1 | BIOCONJUGATES AND DELIVERY OF BIOACTIVE AGENTS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2000-06-14 | — | — | EP | disclosed |
| WO-1998008859-A1 | BIOCONJUGATES AND DELIVERY OF BIOACTIVE AGENTS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1998-03-05 | — | — | WO | disclosed |
| US-5199954-A | Comprising methylcellulose, sorbitol, inorganic metal salt, citric acid, panthenol and water; stability, discoloration inhibition | SHISEIDO CO., LTD. (JP) | 1993-04-06 | — | — | US | disclosed |
| US-4678851-A | FIBER-RACTIVE | CIBA-GEIGY CORPORATION (US) | 1987-07-07 | — | — | US | disclosed |
| EP-0159962-A2 | Fibre-reactive chromium or cobalt complexes, their preparation and their use | CIBA-GEIGY AG (CH) | 1985-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230123911-A1 | MODULATION OF IMMUNE CELLS | IMPDH2, IMPDH1, CD74 | ERN1 1686/4885CDK1 3159/4885TRIM24 2208/4885 |
| US-20020049154-A1 | Bioconjugates and delivery of bioactive agents | CASP3, CASP6, RNPEP | ERN1 3016/4885CDK1 644/4885TRIM24 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.